Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

Market Cap	6.30B
Revenue (ttm)	3.37B
Net Income (ttm)	196.78M
Shares Out	379.33M
EPS (ttm)	0.52
PE Ratio	31.92
Forward PE	n/a
Dividend	0.30 (1.86%)
Ex-Dividend Date	Feb 17, 2025

Volume	46,752,278
Average Volume	49,408,143
Open	16.27
Previous Close	16.60
Day's Range	16.27 - 17.37
52-Week Range	10.65 - 23.22
Beta	0.59
RSI	49.26
Earnings Date	Mar 28, 2025

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.

• Industry: Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 3,657
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300233

Financial Performance

In 2024, SHE:300233's revenue was 3.37 billion, a decrease of -4.66% compared to the previous year's 3.54 billion. Earnings were 196.78 million, an increase of 12.63%.